In prostate cancer cell lines, TAS2R38 was significantly attenuated in two of three cell lines, while the expression pattern of the other investigated TAS2Rs was always diminished in relation to the expression level in a benign prostatic hyperplasia cell line (BPH1) [18]. Here, TAS2R38 is linked to prostate carcinoma.